EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

A Smart CA IX-Targeting and pH-Responsive Nano-Mixed Micelles for Delivery of FB15 with Superior Anti-Breast Cancer Efficacy

XingYun Liu, JingDuo Zhao, FuRong Liu, ZhiZhong Xie iD, XiaoYong Lei, Zhe Wang, Zerui Yang iD, YuSheng Zhou, GuoTao Tang

International Journal of Nanomedicine · 2024

DOI: 10.2147/ijn.s459047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von XingYun Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Nanhua Hospital, Department of Pharmacy, Hengyang Medical School, University of South China, Hengyang, 421001, People's Republic of Ch…. Hauptthemen laut MEDLINE: Carbonic Anhydrase IX, Micelles, Breast Neoplasms, Acetazolamide. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbonic Anhydrase IXMicellesBreast NeoplasmsAcetazolamideFemaleAnimalsHumansHydrogen-Ion ConcentrationMiceCell Line, TumorMice, Inbred BALB CNanoparticlesAntineoplastic AgentsAntigens, NeoplasmVitamin EPolyethylene GlycolsDrug CarriersTumor MicroenvironmentDrug LiberationMice, Nudealpha-TocopherolCarbonic Anhydrase InhibitorsXenograft Model Antitumor Assays

Stichwörter der Autor:innen

FB15carbonic anhydrase IX-targetinghypoxia inducible factor-1nano-mixed micellespH-responsive

Substanzen

Carbonic Anhydrase IXMicellesAcetazolamideAntineoplastic AgentstocophersolanAntigens, NeoplasmVitamin EPolyethylene GlycolsDrug CarriersCA9 protein, human

Autor:innen und Institutionen

  • The Affiliated Nanhua Hospital, Department of Pharmacy, Hengyang Medical School, University of South China, Hengyang, 421001, People's Republic of China.
  • Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, 421001, People's Republic of China.
  • The Second Affiliated Hospital, Department of Pharmacy, Hengyang Medical School, University of South China, Hengyang, 421001, People's Republic of China.
  • NMPA Key Laboratory for Technology Research and Evaluation of Pharmacovigilance, Guangdong Pharmaceutical University, Guangzhou, 510086, People's Republic of China.

ORCID-Profile: ZhiZhong Xie, Zerui Yang

Zitieren

APA

Liu, X., Zhao, J., Liu, F., Xie, Z., Lei, X., Wang, Z., Yang, Z., Zhou, Y., & Tang, G. (2024). A Smart CA IX-Targeting and pH-Responsive Nano-Mixed Micelles for Delivery of FB15 with Superior Anti-Breast Cancer Efficacy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s459047

Vancouver

Liu X, Zhao J, Liu F, Xie Z, Lei X, Wang Z, et al. A Smart CA IX-Targeting and pH-Responsive Nano-Mixed Micelles for Delivery of FB15 with Superior Anti-Breast Cancer Efficacy. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s459047

BibTeX
@article{Liu2024,
  author = {Liu, XingYun and Zhao, JingDuo and Liu, FuRong and Xie, ZhiZhong and Lei, XiaoYong and Wang, Zhe and Yang, Zerui and Zhou, YuSheng and Tang, GuoTao},
  title = {A Smart CA IX-Targeting and pH-Responsive Nano-Mixed Micelles for Delivery of FB15 with Superior Anti-Breast Cancer Efficacy},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  doi = {10.2147/ijn.s459047}
}
Kostenlos starten →